Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies

M Solmi, M De Toffol, JY Kim, MJ Choi, B Stubbs… - bmj, 2023 - bmj.com
Objective To systematically assess credibility and certainty of associations between
cannabis, cannabinoids, and cannabis based medicines and human health, from …

Transition from acute to chronic pain after surgery

P Glare, KR Aubrey, PS Myles - The Lancet, 2019 - thelancet.com
Over the past decade there has been an increasing reliance on strong opioids to treat acute
and chronic pain, which has been associated with a rising epidemic of prescription opioid …

AASLD Practice Guidance: palliative care and symptom‐based management in decompensated cirrhosis

SS Rogal, L Hansen, A Patel, NN Ufere, M Verma… - …, 2022 - Wiley Online Library
Funding for the development of this Practice Guidance was provided by the American
Association for the Study of Liver Diseases. MV was supported by aAQ19 Patient-Centered …

Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational …

E Stockings, G Campbell, WD Hall, S Nielsen, D Zagic… - Pain, 2018 - journals.lww.com
This review examines evidence for the effectiveness of cannabinoids in chronic noncancer
pain (CNCP) and addresses gaps in the literature by: considering differences in outcomes …

[HTML][HTML] Cannabinoids and pain: new insights from old molecules

S Vučković, D Srebro, KS Vujović, Č Vučetić… - Frontiers in …, 2018 - frontiersin.org
Cannabis has been used for medicinal purposes for thousands of years. The prohibition of
cannabis in the middle of the 20th century has arrested cannabis research. In recent years …

[HTML][HTML] Cannabinoid delivery systems for pain and inflammation treatment

N Bruni, C Della Pepa, S Oliaro-Bosso, E Pessione… - Molecules, 2018 - mdpi.com
There is a growing body of evidence to suggest that cannabinoids are beneficial for a range
of clinical conditions, including pain, inflammation, epilepsy, sleep disorders, the symptoms …

Public health implications of legalising the production and sale of cannabis for medicinal and recreational use

W Hall, D Stjepanović, J Caulkins, M Lynskey, J Leung… - The Lancet, 2019 - thelancet.com
We assess the current and describe possible future public health impacts of the legalisation
of cannabis production, sale, and use in the Americas. First, we describe global patterns of …

Neuropathic pain: mechanism-based therapeutics

K Bannister, J Sachau, R Baron… - Annual Review of …, 2020 - annualreviews.org
Neuropathic pain (NeP) can result from sources as varied as nerve compression,
channelopathies, autoimmune disease, and incision. By identifying the neurobiological …

[HTML][HTML] The neuropsychopharmacology of cannabis: A review of human imaging studies

MAP Bloomfield, C Hindocha, SF Green… - Pharmacology & …, 2019 - Elsevier
The laws governing cannabis are evolving worldwide and associated with changing
patterns of use. The main psychoactive drug in cannabis is Δ 9-tetrahydrocannabinol (THC) …

[HTML][HTML] Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study

G Campbell, WD Hall, A Peacock, N Lintzeris… - The Lancet Public …, 2018 - thelancet.com
Background Interest in the use of cannabis and cannabinoids to treat chronic non-cancer
pain is increasing, because of their potential to reduce opioid dose requirements. We aimed …